| Valuation of SF-6Dv2 health states in China using time trade-off and discrete-choice experiment with a duration dimension J Wu, S Xie, X He, G Chen, G Bai, D Feng, M Hu, J Jiang, X Wang, H Wu, ... Pharmacoeconomics 39, 521-535, 2021 | 42 | 2021 |
| Population norms for SF-6Dv2 and EQ-5D-5L in China S Xie, J Wu, F Xie Applied Health Economics and Health Policy 20 (4), 573-585, 2022 | 26 | 2022 |
| Do discrete choice experiments approaches perform better than time trade-off in eliciting health state utilities? Evidence from SF-6Dv2 in China S Xie, J Wu, X He, G Chen, JE Brazier Value in Health 23 (10), 1391-1399, 2020 | 25 | 2020 |
| Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey S Xie, D Wang, J Wu, C Liu, W Jiang Health and Quality of Life Outcomes 20 (1), 96, 2022 | 22 | 2022 |
| The simplified Chinese version of SF-6Dv2: translation, cross-cultural adaptation and preliminary psychometric testing J Wu, S Xie, X He, G Chen, JE Brazier Quality of life research 29, 1385-1391, 2020 | 21 | 2020 |
| Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism M Li, J Li, X Wang, X Hui, Q Wang, S Xie, P Yan, J Tian, J Li, P Xie, ... Cochrane Database of Systematic Reviews, 2023 | 13 | 2023 |
| Canada population norms for the EQ-5D-5L J Yan, S Xie, JA Johnson, E Pullenayegum, A Ohinmaa, S Bryan, F Xie The European Journal of Health Economics 25 (1), 147-155, 2024 | 8 | 2024 |
| The trend in quality of life of Chinese population: analysis based on population health surveys from 2008 to 2020 D Wang, S Xie, J Wu, B Sun BMC Public Health 23 (1), 167, 2023 | 6 | 2023 |
| Totally percutaneous versus surgical cut‐down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair Q Wang, J Wu, Y Ma, Y Zhu, X Song, S Xie, F Liang, M Gimzewska, M Li, ... Cochrane Database of Systematic Reviews, 2023 | 6 | 2023 |
| Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population S Xie, J Wu, G Chen The European Journal of Health Economics 25 (1), 7-19, 2024 | 5 | 2024 |
| Health‐related quality of life among adults with haemophilia in China: A comparison with age‐matched general population W Zhang, S Xie, F Xue, W Liu, L Chen, L Zhang, J Wu, R Yang Haemophilia 28 (5), 776-783, 2022 | 5 | 2022 |
| China health related outcomes measures (CHROME): development of a new generic preference-based measure for the Chinese population J Wu, X He, P Chen, S Xie, X Li, H Hu, K Zhao, F Xie, ... Pharmacoeconomics 40 (10), 957-969, 2022 | 4 | 2022 |
| Endovascular thrombectomy with or without bridging thrombolysis in acute ischemic stroke: a cost-effectiveness analysis RZ Morsi, Y Zhang, M Zhu, S Xie, J Carrión-Penagos, H Desai, E Tannous, ... Neuroepidemiology 58 (1), 47-56, 2024 | 3 | 2024 |
| Comparison of the measurement properties of the EQ-5D-5L and SF-6Dv2 among overweight and obesity populations in China S Xie, M Li, D Wang, T Hong, W Guo, J Wu Health and quality of life outcomes 21 (1), 118, 2023 | 3 | 2023 |
| Discrete choice experiment with duration versus time trade-off: a comparison of test–retest reliability of health utility elicitation approaches in SF-6Dv2 valuation S Xie, J Wu, G Chen Quality of Life Research 31 (9), 2791-2803, 2022 | 3 | 2022 |
| Review of generic preference-based scales for health-related quality of life at the universal scale ST XIE, PN CHEN, XN HE, J WU, F XIE, K ZHAO Chinese Journal of Health Policy, 58-68, 2020 | 3 | 2020 |
| Understanding Canadian stakeholders’ views on measuring and valuing health for children and adolescents: a qualitative study F Xie, S Xie, E Pullenayegum, A Ohinmaa Quality of Life Research 33 (5), 1415-1422, 2024 | 2 | 2024 |
| China Health Related Outcomes Measures (CHROME): development of a descriptive system to support cardiovascular disease specific preference-based measure for the Chinese population X Li, K Zhao, K Li, W Wang, S Feng, J Wu, X He, S Xie, H Hu, J Fan, Q Fu, ... Quality of Life Research 32 (9), 2463-2476, 2023 | 2 | 2023 |
| Valuing Chinese medicine quality of life-11 dimensions (CQ-11D) health states using a discrete choice experiment with survival duration (DCETTO) W Zhu, M Zhang, J Pan, L Shi, H Gao, S Xie Health and Quality of Life Outcomes 21 (1), 99, 2023 | 2 | 2023 |
| PNS240 A COMPARISON OF METHODS FOR ANCHORING DCE-DERIVED LATENT UTILITIES ONTO THE QALY SCALE: EVIDENCE FROM SF-6D V2 S Xie, X He, J Wu, G Chen, JE Brazier Value in Health 22, S326-S327, 2019 | 1 | 2019 |
